Individualised cervical cancer screening, including integrating state-of the-art triage methods to screening

Summary

Survey on existing models, organisational approaches, and member states’ data on risk-based cervical cancer screening will be conducted. Cost-effectiveness scenarios will be defined, informed by the RISCC project and existing pilots, focusing on two risk-stratifications levels: whole population and HPV-positive women. Alignment with existing European recommendations and identification of areas needing new recommendations will be performed defining relevant clinical questions and identifying research priorities. A toolbox will be built for implementing strategies informed by WP4, WP6, and WP10.
This task will be led by AUSLRE, Italy, co-led by ISPRO, Italy.

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen VerticalThe general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

tiktok

FaceBook

X

Instagram

YouTube

LinkedIn

EUCanScreenLogo t

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook

Twitter

Instagram

YouTube

LinkedIn

Logo EU

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Print Friendly, PDF & Email
Μετάβαση στο περιεχόμενο